InsiderTrades

Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-07 · accession 0001209191-22-017736 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-09 2022-03-07 RXRX Gibson Christopher CEO, Dir S - Sale $7.30 -300.0K 234.0K -56% -$2.19M
D 2022-03-09 2022-03-07 RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 +300.0K 534.0K +128% $0
D 2022-03-09 2022-03-07 RXRX Gibson Christopher CEO, Dir C - Cnv Deriv $0.00 -300.0K 7.36M -4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-03-07 S D 300,000 $7.30 234,020 D — — (F4) This transaction was executed in multiple trades at prices ranging from $7.06 to $7.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
2 Common Class A Common Stock 2022-03-07 C A 300,000 $0.00 534,020 D — — (F2) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
3 Derivative Class B Common Stock 2022-03-07 C D 300,000 $0.00 7,358,484 D $0.00 · — to — 7,358,484 Class A Common Stock (F2) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.